Drugmakers Dramatically Boosted Lobbying Spending In Trump’s First Quarter
With high drug prices creating widespread controversy, top pharmaceutical companies and their trade group vastly increased their lobbying spending on Capitol Hill.
Search
Filter
7,741 - 7,760 of 15,443 Results
-
-
Marathon Pharmaceutical Drops Out Of PhRMA Following Drug Price Controversy
Two companies that faced criticism for high-priced drugs, Marathon and Mallinckrodt, have dropped out of the PhRMA trade association.
-
Repeal & Replace Watch
Conservatives’ Goal To Relax Mandatory Health Benefits Unlikely To Tame Premiums
The federal health law requires most insurance plans to offer 10 specific categories of essential benefits. Conservatives would like to get rid of that rule in the hopes of bringing down premium costs.
By Julie Rovner -
What Doesn’t Kill You Can Maim: Unexpected Injuries From Opioids
Doctors are beginning to pay attention to injuries, such as brain damage or kidney failure, that can afflict people who survive an overdose.
-
For Doctors, A Clamp Down On Visas Could Have An Uneven Effect In The U.S.
New research shows that physicians getting H-1B visas account for just over 1 percent of all doctors, but some areas are much more likely to be seeking their services.
-
California Lawmakers Consider Mandatory Labels On Salon Products To Protect Workers
Bill would require disclosure of potentially harmful chemicals used in hair treatments, nail polish and other substances used in salons.
-
How To Help Alzheimer’s Patients Enjoy Life, Not Just ‘Fade Away’
Research shows that people with dementia can benefit significantly from efforts to ease communication, improve overall health and other key measures.
-
San Francisco Seeks To Ban Sale Of Menthol Cigarettes, Flavored Tobacco Products
A proposed ordinance would block access to menthol cigarettes, as well as e-cigarettes and smokeless tobacco with flavors such as chocolate, cherry or popcorn. Studies show such products are overwhelmingly favored by teenagers and some minorities.
By Elaine Korry -
Stalking the ‘Unknown Enemy’: Doctors Turn Scope On Rare Diseases
An NIH-funded network of hospitals uses advanced genetic science and nationwide collaboration to diagnose rare and sometimes undiscovered diseases.
By Anna Gorman -
With Drug Costs In Crosshairs, Health Firms Gave Generously To Trump’s Inauguration
Led by Pfizer and Amgen, about 10 health care firms contributed to President Donald Trump’s inauguration, which earned them entry into private events with the president and vice president.
-
-
Letters to the Editor
Readers: Training Patients To Advocate For Their Illnesses Is ‘A Virtue Not A Sin’
Kaiser Health News gives readers a chance to respond, react and comment on our stories.
-
Trump Extends Flawed ‘Fix’ For VA Health Scandals
The $10 billion plug-in that lets frustrated veterans receive care from private-sector providers is still causing frustration.
-
California Hospitals Lose Ground In Quality Of Care, Report Card Shows
The nonprofit Leapfrog Group shows nearly half of California hospitals got a grade of C, D or F in patient safety measures — an increase from two years ago.
By Chad Terhune -
Nonprofit Linked To PhRMA Rolls Out Campaign To Block Drug Imports
The advocacy group behind an expensive media blitz opposing Canadian drug imports has deep ties to the drug industry’s largest trade group.
By Emily Kopp and Rachel Bluth -
As California Weighs Soda Warning Labels, Tax In Berkeley Shown To Dilute Sales
Sales of sugary drinks dropped in the city by nearly 10 percent a year after tax took effect in 2015, while bottled water sales rose, researchers report.
-
Sen. Grassley Demands Scrutiny Of Medicare Advantage Plans
The powerful chairman of the Senate Judiciary Committee wants the Centers for Medicare and Medicaid Services to explain $125 million in overcharges by insurers.
By Fred Schulte -
Kids With Hepatitis C Get New Drugs And Coverage May Prove Easier Than For Adults
The drugs, approved by the FDA for children earlier this month, can run $100,000 for a course of treatment.
-
A New Worry For Smokers’ Families: ‘Thirdhand Smoke’
The chemical residue from cigarette smoke that can cling to walls, clothes and skin may present a danger to children.
-
Repeal & Replace Watch
Florida Congressman Draws Jeers At Home For Backing Failed GOP Health Care Plan
Rep. Brian Mast, a first-term Republican congressman, defends his party’s push to repeal Obamacare in a meeting with constituents but concedes its health care plan needs more work.